Gene Query: RBBP4

Dataset Description Geneva Score
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 37.41
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 35.64
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 34.21
RIG-I and MDA5 fRIP during KSHV lytic reactivation 32.61
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 31.38
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 28.91
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 24.8
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 24.69
Role of microRNAs in the interaction between Salmonella and the host cell 24.11
Sensing self and nonself circular RNAs 22.74
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 22.49
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 21.09
Determination of tRNA aminoacylation levels by high throughput sequencing 20.79
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 20.22
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 20.16
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 20.07
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 19.77
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 19.76
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 19.03
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 18.93
Co-transcriptional loading of RNA export factors shapes the human transcriptome 18.92
RNAseq of HEK293 cells after Chtop knockdown 18.92
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 18.41
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 17.84
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 17.6
Efficient and quantitative high-throughput tRNA sequencing 17.53
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 17.09
Identification of Nrf2 regulated genes by RNA sequencing 16.97
Nrf2 regulated genes in A549 cells 16.97
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 16.91
Transcriptomic analyssis following EHMT1/2 inhibition 16.85
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 16.2
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 14.99
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 14.61
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 14.11
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 14.03
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 13.97
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 13.94
Transcriptomic analysis of the HOTAIR-regulated genes 13.85
Role of XRN2 ribonucleolytic activity in RNA metabolism 13.64
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 13.47
The regulartory role of ZCCHC24 in splicing machinery 13.32
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 13.09
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 12.94
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 12.93
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 12.88
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 12.84
3’ Uridylation Expands miRNA Target Repertoire 12.6
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 12.34
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 12.28
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 12.28
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 12.17
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 12.05
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.95
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 11.95
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 11.86
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 11.82
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 11.78
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 11.74
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 11.56
Short and Long RNA sequencing of human mature erythrocytes 11.53
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.39
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 11.33
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 11.21
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 11.09
RNA-Seq of PRMT1 overexpression ECA109 cells 11.05
Profiling of escape kinetics of viruses subjected to RNAi 11.01
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 10.81
Differential analysis of gene regulation at transcript resolution by RNA-Seq 10.73
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 10.73
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 10.72
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 10.62
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 10.55
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 10.55
MARS Seq data from human cortical organoids 10.49
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 10.49
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 10.42
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 10.14
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 10.14
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 10.01
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 9.99
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 9.99
Expression profiling of etoposide-induced senescent cells 9.94
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 9.94
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 9.93
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 9.92
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 9.92
RNA-Seq with and without RNase treatment in PCa cell lines 9.9
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 9.87
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 9.84
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 9.75
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 9.73
Unique features and clinical importance of acute alloreactive immune responses 9.69
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 9.56
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.54
RNA transcriptome analysis during HSV-1 infection 9.49
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 9.45
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 9.27
RNA-sequencing in irradiated and normal A549 cells. 9.22
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 9.17
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 9.16
Differentially expressed vascular development genes for iPSC-ECs from CDI 9.07
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.98
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 8.97
Global analysis of enhancer targets: Mosaic-seq 8.96
Expression by CD133+ cells isolated from the adult human exocrine pancreas 8.96
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 8.92
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 8.91
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 8.91
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.9
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.9
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 8.9
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 8.89
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.88
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.82
The cohesin complex prevents Myc-induced replication stress 8.72
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 8.65
Ribosomal footprinting of CN34-Parental and CN34-LM1a 8.6
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 8.49
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 8.49
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 8.48
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 8.47
HBEC-shp53-PCHD7 8.45
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 8.42
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 8.31
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.29
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 8.25
Stem and effector CD8 T-cells from human cancers 8.23
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 8.18
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 8.18
An RNA-centric dissection of host complexes controlling flavivirus infection 8.17
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 8.17
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 8.15
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 8.1
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 8.1
Crizotinib v. DMSO in SW480 cells 8.1
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 8.04
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 8.04
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 8.0
CROP-Seq in Primary Human T Cells 8.0
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 7.98
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 7.93
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 7.91
Small-molecule targeting of brachyury transcription factor addiction in chordoma 7.88
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 7.87
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 7.81
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 7.78
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 7.78
MYCi361 regulates MYC target genes 7.7
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 7.65
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 7.65
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 7.61
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 7.56
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 7.55
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 7.5
DJ-1 is dispensable for human stem cell homeostasis 7.47
Genome-wide functional assessment of enhancer activities in the human genome 7.47
Defective structural RNA processing in relapsing-remitting multiple sclerosis 7.46
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 7.46
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 7.45
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 7.44
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 7.44
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 7.39
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 7.39
Identification of Atrial Fibrillation associated genes and functional non-coding variants 7.37
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 7.36
RNA-Seq analysis of breast cancer cells after shikonin treatment 7.34
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 7.29
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 7.28
RNA-seq of MDA-MB-231 cells with TET1 knockout 7.27
Ribosomal footprinting of MDA-Parental and MDA-LM2 7.26
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 7.23
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 7.23
Survival of pancreatic cancer cells lacking KRAS function 7.2
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 7.16
mRNA expression in human DAOY cells 7.13
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 7.11
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 7.1
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 7.1
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 7.1
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 7.1
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 7.07
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 7.07
G-quadruplex structures mark human regulatory chromatin 7.02
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 7.01
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 7.01
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 7.01
Exploring the RNA landscape of endothelial exosomes 7.01
MicroRNA targetome analysis during HCMV infection 6.96
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 6.95
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 6.93
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 6.93
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 6.93
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 6.93
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 6.89
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 6.89
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.86
Single-nucleotide-resolution mapping of HBV promoters using CAGE 6.84
The human blood-nerve barrier transcriptome 6.8
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 6.79
An optimization system for isolating and sequencing of single human colon cancer cells 6.77
RNA-seq analysis of differentiating human erythroblasts 6.74
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 6.73
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 6.71
scRNASeq analysis of cycling cardiomyocytes 6.69
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 6.69
Differentiation enhances Zika virus infection in neuronal brain cells 6.67
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.67
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 6.66
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 6.66
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 6.65
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 6.64
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 6.62
Gene expression patterns define the hepatocyte-like cells derived by different strategies 6.57
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 6.57
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 6.5
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 6.46
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 6.45
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 6.44
SLIGRL-induced gene expression changes in NHEK cells 6.42
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 6.39
mRNA expression profile of Lymphocytes 6.36
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 6.34
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.33
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 6.32
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 6.29
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 6.28
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.26
Regulation of hypoxia-inducible factor activity by ZMYND8 6.25
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 6.2
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 6.19
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 6.19
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 6.19
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 6.17
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 6.14
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.11
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.11
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 6.11
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 6.09
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 6.05
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 6.04
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 6.02
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 6.0
ZIKV infection of monocytes activates inflammasome pathways 6.0
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 5.99
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.96
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 5.9
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 5.89
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 5.85
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 5.84
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 5.78
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 5.76
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 5.75
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 5.7
hnRNP C is a key regulator of protein synthesis in mitosis 5.68
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.64
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.64
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.62
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.62
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.62
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 5.55
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.55
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 5.54
Differetially expressed genes after hTR overexpression in U2OS cells 5.5
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 5.32
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 5.32
Characterization of the Merkel cell carcinoma miRNome 5.3
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 5.29
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 5.18
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 5.16
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 5.16
The transcriptome and chromatin accessbility landscape of mammalian germline 5.13
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 5.07
PTHrP overexpression in MCF7 cells 5.03
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 5.01
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 5.01
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 5.0
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 5.0
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 4.97
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 4.96
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 4.92
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 4.92
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.88
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 4.83
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 4.83
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 4.79
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 4.79
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 4.78
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 4.71
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 4.71
Differential Protein Occupancy Profiling of the mRNA Transcriptome 4.71
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 4.69
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 4.69
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 4.67
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 4.65
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 4.6
RNA-seq of RKO cells with cTAZ KO or putback 4.57
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 4.51
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 4.43
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.43
EWS-Fli and LNC regulated genes in comparison to GFP samples 4.42
RNA polymerase in pre-B-ALL cell lines 4.42
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 4.36
The transcriptome effect of overexpressing EZH2 in MCF7 4.3
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 4.26
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.26
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.26
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.24
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 4.22
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.22
Transcriptome analysis of CNS leukemia 4.22
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.2
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.18
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.15
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.15
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.03
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.98
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 3.96
Global response to chemotherapy-induced apoptosis 3.93
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.93
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.92
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 3.92
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.91
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 3.9
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 3.87
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.85
RNAseq in Alzheimer's Disease patients 3.82
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 3.79
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.74
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 3.71
Novel Targeting of Transcription and Metabolism in Glioblastoma 3.69
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  3.64
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 3.64
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 3.62
miR-93 Targets in Human Endothelial Cells 3.57
Transcriptome analysis of peripheral blood monocytes 3.57
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 3.55
A code of mono-phosphorylation modulates the function of RB. 3.54
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 3.47
Recovery and analysis of nascent RNA 3.47
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.46
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.46
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.41
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.41
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.41
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.39
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 3.33
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 3.31
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.23
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 3.23
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 3.19
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 3.18
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 3.17
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 3.17
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.1
N6-methyladenine DNA Modification in Glioblastoma 3.1
High-resolution comparative analysis of great ape genomes 3.1
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.08
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 3.06
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 3.04
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.03
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.98
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 2.98
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 2.94
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 2.92
RNA-seq of IL-4 stimulated human keratinocytes 2.91
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 2.88
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.86
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.83
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.83
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 2.81
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 2.71
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.7
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 2.67
Human cells contain natural double-stranded RNAs with potential regulatory capacity 2.65
CDK12 mediated transcriptional regulation in U2OS cells 2.64
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.62
LINE-2 transposable elements are a source of functional human microRNAs and target sites 2.51
In vitro modeling of human germ cell development using pluripotent stem cells 2.5
Metabolism as an early predictor of DPSCs aging 2.47
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.42
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.39
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.39
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 2.39
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.35
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.33
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.32
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.31
Induction of Cardiomyocyte Proliferation [pz-822_human] 2.29
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 2.29
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.28
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.24
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.24
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.22
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.22
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.2
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 2.19
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.17
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 2.15
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 2.14
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.08
Capturing the Interactome of Newly Transcribed RNA 2.08
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.05
Triple vectors expand AAV transfer capacity in the retina 2.03
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.99
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.98
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.96
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 1.96
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.95
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.94
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.9
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.9
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.87
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.87
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.83
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.82
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 1.82
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.77
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.77
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.77
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.75
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.67
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.63
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.6
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.6
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.59
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.58
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.57
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.57
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 1.55
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.55
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.53
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.53
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.53
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.5
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.5
Transposon-based construction of strand-specific RNA-seq libraries 1.48
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.42
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 1.39
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.39
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.38
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.37
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.37
naive T cell heterogeneity after neonatal thymectomy 1.33
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.28
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.25
Human Treg IL-12 stimulation 1.24
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.22
Solid phase chemistry to covalently and reversibly capture thiolated RNA 1.21
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 1.21
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.19
Hepatic transcriptome of pediatric hepatoblastoma. 1.17
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.16
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.13
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 1.08
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.08
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 1.02
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.02
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.98
Human Tfh cell RNA bulk sequencing 0.97
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.94
Human Treg IFNg/IL-10 subpopulations 0.85
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.82
Transcriptomic profiling of human peripheral blood-derived mast cells 0.82
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.81
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.79
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.77
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.75
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.69
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.68
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.68
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.63
RNA-seq of primary patient AML samples 0.59
Specific molecular signatures underlie response to decitabine in CMML 0.56
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.56
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.55
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.55
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.51
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.5
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.38
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.36
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.33
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.33
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.32
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.32
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.27
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.27
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.27
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.23
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.18
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 0.16
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.15
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.15
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.14
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.09
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.08
Interphase condensins regulate ligand-depedent enhancer activation 0.05
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.05
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation